Stem Cell Authority Cash Flow Statement

Financials in millions USD. Fiscal year is September - August.

Millions USD. Fiscal year is Sep - Aug.

Fiscal Year	FY 2009	FY 2008	FY 2007	FY 2006	FY 2005	2001 - 2004
Period Ending	Aug '09 Aug 31, 2009	Aug '08 Aug 31, 2008	Aug '07 Aug 31, 2007	Dec '06 Dec 31, 2006	Dec '05 Dec 31, 2005	2001 - 2004
Net Income	-	-	0.95	-0.66	-0.05	Upgrade
Depreciation & Amortization	-	-	0.01	-	-	Upgrade
Change in Inventory	-	-	-0.03	-	-	Upgrade
Change in Other Net Operating Assets	-	-	-0.05	-0.04	-	Upgrade
Operating Cash Flow	-	-	0.13	-0.7	-0.05	Upgrade
Capital Expenditures	-	-	-0.12	-	-	Upgrade
Investing Cash Flow	-	-	-0.12	-	-	Upgrade
Short-Term Debt Issued	-	-	-	0.67	0.05	Upgrade
Total Debt Issued	-	-	0.11	0.67	0.05	Upgrade
Total Debt Repaid	-	-	-0.01	-	-	Upgrade
Net Debt Issued (Repaid)	-	-	0.1	0.67	0.05	Upgrade
Issuance of Common Stock	-	-	0.01	0.03	-	Upgrade
Financing Cash Flow	-	-	0.11	0.7	0.05	Upgrade
Net Cash Flow	-	-	0.12	0	-	Upgrade
Free Cash Flow	-	-	0.01	-0.7	-0.05	Upgrade
Free Cash Flow Margin	-	-	1.28%	-	-	Upgrade
Free Cash Flow Per Share	-	-	-	-0.01	-0.00	Upgrade
Levered Free Cash Flow	-	-	-	-0.35	-	Upgrade
Unlevered Free Cash Flow	-	-	-	-0.33	-	Upgrade
Change in Working Capital	-	-	-0.84	-0.04	-	Upgrade

Source: S&P Global Market Intelligence. Standard template. Financial Sources.